Lonza Group Ltd
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract develo… Read more
Lonza Group Ltd (LZAGF) - Total Liabilities
Latest total liabilities as of December 2025: $9.78 Billion USD
Based on the latest financial reports, Lonza Group Ltd (LZAGF) has total liabilities worth $9.78 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lonza Group Ltd - Total Liabilities Trend (2004–2025)
This chart illustrates how Lonza Group Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lonza Group Ltd Competitors by Total Liabilities
The table below lists competitors of Lonza Group Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Orsted A/S
PINK:DOGEF
|
USA | $239.39 Billion |
|
Waste Connections Inc
NYSE:WCN
|
USA | $13.00 Billion |
|
Entergy Corporation
NYSE:ETR
|
USA | $52.87 Billion |
|
Public Service Enterprise Group Inc
NYSE:PEG
|
USA | $40.59 Billion |
|
Baidu Inc
NASDAQ:BIDU
|
USA | $159.43 Billion |
|
Oversea-Chinese Banking Corporation Limited
PINK:OVCHF
|
USA | $583.27 Billion |
|
Larsen & Toubro Limited
PINK:LTOUF
|
USA | $2.71 Trillion |
Liability Composition Analysis (2004–2025)
This chart breaks down Lonza Group Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lonza Group Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lonza Group Ltd (2004–2025)
The table below shows the annual total liabilities of Lonza Group Ltd from 2004 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $9.78 Billion | -5.46% |
| 2024-12-31 | $10.35 Billion | +41.02% |
| 2023-12-31 | $7.34 Billion | +9.64% |
| 2022-12-31 | $6.69 Billion | +0.83% |
| 2021-12-31 | $6.64 Billion | -12.05% |
| 2020-12-31 | $7.54 Billion | +3.70% |
| 2019-12-31 | $7.28 Billion | -4.65% |
| 2018-12-31 | $7.63 Billion | +1.25% |
| 2017-12-31 | $7.54 Billion | +68.50% |
| 2016-12-31 | $4.47 Billion | +8.75% |
| 2015-12-31 | $4.11 Billion | -4.59% |
| 2014-12-31 | $4.31 Billion | -2.36% |
| 2013-12-31 | $4.42 Billion | -5.94% |
| 2012-12-31 | $4.69 Billion | +0.64% |
| 2011-12-31 | $4.66 Billion | +95.06% |
| 2010-12-31 | $2.39 Billion | -6.42% |
| 2009-12-31 | $2.56 Billion | -18.71% |
| 2008-12-31 | $3.14 Billion | 0.00% |
| 2007-12-31 | $3.14 Billion | +36.36% |
| 2006-12-31 | $2.31 Billion | -18.87% |
| 2005-12-31 | $2.84 Billion | +38.18% |
| 2004-12-31 | $2.06 Billion | -- |